Author: admin

Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology

BANNOCKBURN, Ill. and DURHAM, North Carolina, February 25, 2016 – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients...


Precision BioSciences Announces Appointment of Gene Liau, Ph.D. and Bruce McCreedy, Ph.D. to Management Team

RESEARCH TRIANGLE PARK, North Carolina, September 2nd, 2015 – Precision BioSciences, the genome editing company, today announced two key additions to the executive team – Gene Liau, Ph.D., as...


Precision BioSciences Announces $25.6 Million Series A Financing

RESEARCH TRIANGLE PARK, North Carolina, May 11, 2015 – Precision BioSciences, the genome editing company, today announced the closing of a $25.6 million Series A financing led by venBio. Joining in...